EPITHELIOD MALIGNANT PLEURAL MESOTHELIOMA

Clinical trials for EPITHELIOD MALIGNANT PLEURAL MESOTHELIOMA explained in plain language.

Never miss a new study

Get alerted when new EPITHELIOD MALIGNANT PLEURAL MESOTHELIOMA trials appear

Sign up with your email to follow new studies for EPITHELIOD MALIGNANT PLEURAL MESOTHELIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Light-Activated drug tested in battle against rare cancer

Disease control Ongoing

This study is testing whether adding a special light-activated drug treatment during surgery helps people with a specific type of lung cancer (epithelioid malignant pleural mesothelioma) live longer. All participants have surgery to remove as much cancer as possible, followed by …

Matched conditions: EPITHELIOD MALIGNANT PLEURAL MESOTHELIOMA

Phase: PHASE2 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control

Last updated Mar 30, 2026 14:35 UTC

EPITHELIOD MALIGNANT PLEURAL MESOTHELIOMA

Get alerted when new EPITHELIOD MALIGNANT PLEURAL MESOTHELIOMA trials appear

Light-Activated drug tested in battle against rare cancer